← Open Payments lookup

BECHOY ABDELMALAK: Open Payments

NPI 1134526981 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$887 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $163 · 2025 $887

Food & beverage: $775Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$174
Teva Pharmaceuticals USA, Inc.3$137
Axsome Therapeutics, Inc.4$106
Supernus Pharmaceuticals, Inc.5$91
Lundbeck LLC4$79
E.R. Squibb & Sons, L.L.C.3$71
Corium, LLC2$63
Janssen Pharmaceuticals, Inc2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Takeda Pharmaceuticals U.S.A., Inc.1$33

Products named: REXULTI, Auvelity, Qelbree, ABILIFY ASIMTUFII, COBENFY, Azstarys, SPRAVATO, CAPLYTA.

Industry payments across NY — which companies pay providers there.